Chromatin immunoprecipitation-sequencing (ChIP-seq) analysis using anti-AR antibodies showed a marked increase in AR binding to genomic regions encompassing the transcription start sites (TSS) in A375 melanoma cells after 48 hours of DAB treatment (Fig. 3a). This evidence concerns the gene AR and melanoma.